Clinical Trials Directory

Trials / Completed

CompletedNCT03415503

Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent Manner

Anthocyanin Supplementation Improves Blood Lipids in a Dose-response Manner in Subjects With Dyslipidemia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
169 (actual)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
35 Years – 70 Years
Healthy volunteers
Not accepted

Summary

In order to study the effect of anthocyanins on the improvement of glucose and lipid metabolism, randomized intervention trials were conducted to compare the effects of anthocyanins on the improvement of glucose and lipid metabolism in different dose groups.To explore the best dose of anthocyanins for the prevention and treatment of anthocyanin metabolic diseases provide an important scientific basis.

Detailed description

In order to study the effect of anthocyanins on the improvement of glucose and lipid metabolism, randomized controlled trials were conducted to enrolled 300 patients with dyslipidemia. The subjects were divided into 0 mg / d, 40 mg / d, 80 mg / d, 320 mg/ d five dose groups, intervention for 12 weeks, comparing different doses of anthocyanins on glucose and lipid metabolism.To explore the best dose of anthocyanins for the prevention and treatment of anthocyanin metabolic diseases provide an important scientific basis.

Conditions

Interventions

TypeNameDescription
DRUGMedox® Anthocyanin capsulesSubjects were orally administered Medox® capsules daily for 12 weeks.

Timeline

Start date
2018-10-01
Primary completion
2019-10-01
Completion
2019-10-01
First posted
2018-01-30
Last updated
2020-11-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03415503. Inclusion in this directory is not an endorsement.